ES2039265T3 - Procedimiento mejorado para la preparacion de benzo-(calcogeno) (4,3,2-cd)indazoles. - Google Patents

Procedimiento mejorado para la preparacion de benzo-(calcogeno) (4,3,2-cd)indazoles.

Info

Publication number
ES2039265T3
ES2039265T3 ES198888104592T ES88104592T ES2039265T3 ES 2039265 T3 ES2039265 T3 ES 2039265T3 ES 198888104592 T ES198888104592 T ES 198888104592T ES 88104592 T ES88104592 T ES 88104592T ES 2039265 T3 ES2039265 T3 ES 2039265T3
Authority
ES
Spain
Prior art keywords
calcogen
benzo
indazoles
preparation
improved procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888104592T
Other languages
English (en)
Inventor
Vladimir Genukh Beylin
Om Prakash Goel
Anthony Denver Sercel
Howard Daniel Hollis Showalter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of ES2039265T3 publication Critical patent/ES2039265T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

PROCESOS MEJORADOS PARA PRODUCIR BENZO(CALCOGENO) [4,3,2-CD] INDAZOLES SUSTITUIDOS. LOS PROCESOS PRODUCEN COMPUESTOS CON GRAN RENDIMIENTO Y DE MAYOR PUREZA USANDO UNA NUEVA SECUENCIA DE QUIMICA DE ACILACION Y GRUPOS DE PROTECCION FACILMENTE SEPARABLES. LOS COMPUESTOS PRODUCIDOS TIENEN ACTIVIDAD ANTIBACTERIANA, ANTIFUNGICA, ANTILEUCEMICA Y ANTITUMORAL.
ES198888104592T 1987-03-23 1988-03-22 Procedimiento mejorado para la preparacion de benzo-(calcogeno) (4,3,2-cd)indazoles. Expired - Lifetime ES2039265T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2902187A 1987-03-23 1987-03-23
US07/149,103 US4806654A (en) 1987-03-23 1988-02-11 Processes for the preparation of benzo(chalcogeno)(4,3,2-cd)indazoles and intermediates thereof

Publications (1)

Publication Number Publication Date
ES2039265T3 true ES2039265T3 (es) 1993-09-16

Family

ID=26704423

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888104592T Expired - Lifetime ES2039265T3 (es) 1987-03-23 1988-03-22 Procedimiento mejorado para la preparacion de benzo-(calcogeno) (4,3,2-cd)indazoles.

Country Status (15)

Country Link
US (1) US4806654A (es)
EP (1) EP0284966B1 (es)
JP (1) JP2648165B2 (es)
KR (1) KR960001477B1 (es)
AU (1) AU605551B2 (es)
DE (1) DE3867280D1 (es)
DK (1) DK174623B1 (es)
ES (1) ES2039265T3 (es)
FI (1) FI93730C (es)
GR (1) GR3003513T3 (es)
IE (1) IE61090B1 (es)
NO (1) NO171161C (es)
NZ (1) NZ223761A (es)
PH (1) PH25229A (es)
PT (1) PT87040B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ303528A (en) * 1995-02-27 1998-08-26 Sanofi Winthrop Inc Benzothiopyran[4,3,2-cd]indazole derivatives and medicaments
US6747039B2 (en) 2002-03-12 2004-06-08 Albany Molecular Research, Inc. Aza-benzothiopyranoindazoles with antitumor activity

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1381442A (en) * 1972-05-02 1975-01-22 Searle & Co Process for the preparation of prostaglandin precursors
CH577464A5 (es) * 1972-09-22 1976-07-15 Ciba Geigy Ag
JPS559517B2 (es) * 1973-07-16 1980-03-10
CA1206153A (en) * 1983-01-06 1986-06-17 Donald F. Worth Benzothiopyrano ¬4,3,2-cd| indazole compositions and methods for their production and use
US4604390A (en) * 1983-01-06 1986-08-05 Warner-Lambert Company Antibacterial benzo(chalcogeno)[4,3,2-cd]indazoles
CA1251450A (en) * 1984-06-29 1989-03-21 David B. Capps Benzopyrano¬4,3,2-cd|indazole compositions and methods for their production and use
CA1251451A (en) * 1984-06-29 1989-03-21 Ellen M. Berman Benzoseleno¬4,3,2-cd|indazole compositions and methods for their production and use

Also Published As

Publication number Publication date
JPS646277A (en) 1989-01-10
NO171161B (no) 1992-10-26
NZ223761A (en) 1990-10-26
DK156888A (da) 1988-09-24
IE61090B1 (en) 1994-09-21
FI93730B (fi) 1995-02-15
US4806654A (en) 1989-02-21
FI881327A0 (fi) 1988-03-21
DK156888D0 (da) 1988-03-22
NO171161C (no) 1993-02-03
NO881251D0 (no) 1988-03-22
DE3867280D1 (de) 1992-02-13
AU1212488A (en) 1988-09-22
AU605551B2 (en) 1991-01-17
JP2648165B2 (ja) 1997-08-27
DK174623B1 (da) 2003-07-28
PT87040A (pt) 1988-04-01
EP0284966A1 (en) 1988-10-05
IE880488L (en) 1988-09-23
FI93730C (fi) 1995-05-26
PT87040B (pt) 1992-07-31
KR880011156A (ko) 1988-10-26
PH25229A (en) 1991-03-27
FI881327A (fi) 1988-09-24
NO881251L (no) 1988-09-26
KR960001477B1 (ko) 1996-01-31
EP0284966B1 (en) 1992-01-02
GR3003513T3 (es) 1993-03-16

Similar Documents

Publication Publication Date Title
DE3366011D1 (en) Preparation of pyrrolo-(3,4-c) pyrroles
GR58260B (en) Nouveaux medicaments derives de l'indole
IT1217346B (it) Prodotto comprendente un composto organico del silicato combinato con una sostanza cosmeticamente attiva
AU532217B2 (en) Preparation of 4,1:,6:-tricholoro-4,1:,6: -trideoxy - galactosucrose
AU4269778A (en) Production of encapsulated' active substances
JPS5528986A (en) Novel administration form
GB2034307B (en) Preparation of 1,1-diesters
CA1021778A (en) Preparation of optically active 1,4-benzodiazepin-2-one derivatives
JPS5228945A (en) Pharmaceutically active ooacyll 2*33diaryll33halogenn acrylaldoxim
ZA801261B (en) Highly active silver cathode, preparation of same and use to make 2,3,5-trichloro-pyridine
ES493481A0 (es) Procedimiento para preparar 2,7-dioxo-2,7-dihidroben- zo-(1:2-b;5:6-b1)difurano o -dipirrol
ES2039265T3 (es) Procedimiento mejorado para la preparacion de benzo-(calcogeno) (4,3,2-cd)indazoles.
DE3164870D1 (en) Preparation of insecticidal mixture of stereoisomers of alpha-cyano-3-phenoxybenzyl isovalerates
IT1174301B (it) Proccedimento per produrre polipropi lene di migliore stirabilita'
GB2048868B (en) Preparation of 2',6'-dialkyl - n - alkoxymethyl - 2 - chloroacetanilides
IT1188797B (it) Composti di azepino (1,2,3-lm) beta-carbolina e relativo procedimento per prepararli
IL56297A0 (en) Novel phosphoramidothioate derivatives, their preparation and their use for combating pests
FR2519982B1 (fr) Nouveaux derives de l'indoline, leur preparation et leur utilisation comme medicaments
FI782639A (fi) Loesgoering av fd&c red nr 3 i sura foerhaollande och komplikationer innehaollande dem
DE2966322D1 (en) Pharmaceutically active 6,9-thiaprostacyclin analogs and derivatives thereof
AU499507B2 (en) Crossbar" telecommunication wiring aid
IL53165A (en) Preparation of 2,4,5,6-tetra-aminopyrimidine
IL60230A0 (en) Preparation of 3,3-dimethyl-allyl alcohol
GB2060631B (en) Preparation of 2-oxo-dihydrobenzo-(d)(1,3)-oxazines
FI793333A (fi) 4,4-dimetyl-4-sila-fettsyraamider framstaellning av dem och farmaceutiska preparat innehaollande dessa

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 284966

Country of ref document: ES